1 Min Read
Dec 13 (Reuters) - GlaxoSmithKline Plc :
* Submits regulatory application in Japan for belimumab in systemic lupus erythematosus Further company coverage: (Bengaluru Newsroom)
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2017 Reuters. All Rights Reserved.